![Franziska Michor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Franziska Michor
Direktor/Vorstandsmitglied bei
EXSCIENTIA PLC
Vermögen: 790 801 $ am 30.06.2026
Profil
Franziska Michor is the founder of Harbinger Health, Inc., founded in 2020.
Current jobs include Independent Director at Recursion Pharmaceuticals, Inc. since 2023, Director at Exscientia Ltd. since 2023, Director at Dana-Farber Cancer Institute, Inc., and Professor at Harvard University.
Education history includes a doctorate from Harvard University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.06.2026 | 215’477 ( 0.04% ) | 790 801 $ | 30.06.2026 |
Aktive Positionen von Franziska Michor
| Unternehmen | Position | Beginn |
|---|---|---|
| EXSCIENTIA PLC | Direktor/Vorstandsmitglied | 03.05.2023 |
| RECURSION PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.05.2023 |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Franziska Michor
| Unternehmen | Position | Ende |
|---|---|---|
Harbinger Health
 Harbinger Health Information Technology ServicesTechnology Services Develops health technology that pioneering the detection of cancer | Gründer | - |
Ausbildung von Franziska Michor
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
57
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Recursion Pharmaceuticals, Inc.
 Recursion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that combines biology, chemistry, automation, data science and engineering to industrialize drug discovery | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Health Services |
Exscientia Plc
 Exscientia Plc Packaged SoftwareTechnology Services Function as an investment holding company whose subsidiaries provides artificial intelligence and machine learning services | Technology Services |
Harbinger Health
Harbinger Health Information Technology ServicesTechnology Services Develops health technology that pioneering the detection of cancer | Technology Services |
